By: Keith Speights
Key Points Pfizer's COVID-19 products continue to generate significant cash flow that helps bolster the company's dividend. The big drugmaker has opportunities to monetize assets to raise additional cash. Pfizer's new products and ones potentially on the way reduce the risk to its dividend. Motley Fool Issues Rare “All In” Buy Alert